Compare Kurniamitra Duta Sentosa Tbk. (KMDS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kurniamitra Duta Sentosa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Kurniamitra Duta Sentosa Tbk. trades at Rp525 (market cap 416B, 126.8K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kurniamitra Duta Sentosa Tbk. is far larger — about 4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KMDS | SCPI | |
|---|---|---|
Market Cap | 416B | 104.4B |
Volume | 126.8K | — |
Lot | 1.27K | — |
Turnover | 65.84M | — |
Average Price | 519.26 | — |
Value | 65.84M | — |
Indicative Equilibrium Price | 525 | — |
Indicative Equilibrium Volume | 30 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kurniamitra Duta Sentosa Tbk.
PT Kurniamitra Duta Sentosa Tbk ("Company") was established based on Deed No. 21 July 17, 2000, which was made before the Notary Kun Hidayat, SH. The company started its commercial operations since July 17, 2000
Read more on KMDS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
